Incidence of 30-Day Venous Thromboembolism in Adults Tested for SARS-CoV-2 Infection in an Integrated Health Care System in Northern California
Open Access
- 1 July 2021
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Internal Medicine
- Vol. 181 (7) , 997-999
Abstract
Hospitalization for COVID-19 is associated with high rates of venous thromboembolism (VTE).1 Whether SARS-CoV-2 infection affects the risk of VTE outside of the hospital setting remains poorly understood. We report on the 30-day incidence of outpatient and hospital-associated VTE following SARS-CoV-2 testing among adult members of the Kaiser Permanente Northern California health plan.Keywords
This publication has 6 references indexed in Scilit:
- Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular MedicineThrombosis and Haemostasis, 2020
- Postdischarge venous thromboembolism following hospital admission with COVID-19Blood, 2020
- Prevention, Diagnosis, and Treatment of VTE in Patients With Coronavirus Disease 2019Chest, 2020
- Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation serviceThrombosis Research, 2020
- Thrombosis in Hospitalized Patients With COVID-19 in a New York City Health SystemJAMA, 2020
- Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical IllnessNew England Journal of Medicine, 2018